Regional Differences in Apolipoprotein E Polymorphism in Finland

References

• Shore V G., Shore B. Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry 1973; 12: 502–7
   PubMed Web of Science ®Google Scholar
• Mahley R W., Innerarity T L., Rall S C., Jr, Weisgraber K H. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984; 25: 1277–94
   PubMed Web of Science ®Google Scholar
• Brown M S., Goldstein J L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34–47
   PubMed Web of Science ®Google Scholar
• Kowal R C., Herz J, Goldstein J L., Esser V, Brown M S. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apolipoprotein E-enriched lipoproteins. Proc Natl Acad Sci U S A 1989; 86: 5810–4
   PubMed Web of Science ®Google Scholar
• Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 1977; 269: 604–7
   PubMed Web of Science ®Google Scholar
• Zannis V I., Just P W., Breslow J L. Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 1981; 33: 11–24
   PubMed Web of Science ®Google Scholar
• Sing C F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985; 37: 268–85
   PubMed Web of Science ®Google Scholar
• Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986; 27: 227–35
   PubMed Web of Science ®Google Scholar
• Eto M, Watanabe K, Ishii K. Reciprocal effects of apolipoprotein E alleles (ϵ2 and ϵ4) on plasma lipid levels in normolipidemic subjects. Clin Genet 1986; 29: 477–84
   PubMed Web of Science ®Google Scholar
• Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987; 113: 433–40
   PubMed Web of Science ®Google Scholar
• Ordovas J M., Litwack-Klein L, Wilson P WF, Schaefer M M., Schaefer E J. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 1987; 28: 371–80
   PubMed Web of Science ®Google Scholar
• Lehtimäki T, Moilanen T, Viikari J, et al. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990; 31: 487–95
   PubMed Web of Science ®Google Scholar
• Menzel H J., Kladetzky R G., Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 1983; 3: 310–5
   PubMedGoogle Scholar
• Cumming A M., Robertson F W. Polymorphism at the apoprotein-E locus in relation to risk of coronary diseasae. Clin Genet 1984; 25: 310–3
   PubMed Web of Science ®Google Scholar
• Utermann G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 1984; 65: 237–41
   PubMed Web of Science ®Google Scholar
• Lenzen H J., Assmann G, Buchwalsky R, Schulte H. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem 1986; 32: 778–81
   PubMed Web of Science ®Google Scholar
• Davignon J, Gregg R E., Sing C F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1–21
   PubMedGoogle Scholar
• Kuusi T, Nieminen M S., Ehnholm C, et al. Apoprotein-E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 1989; 9: 237–41
   PubMedGoogle Scholar
• Åkerblom H K., Viikari J, Räsänen L, Kuusela V, Uhari M, Lautala P. Cardiovascular risk in young Finns, results from the second follow-up study. Ann Med 1989; 21: 223–5
   PubMed Web of Science ®Google Scholar
• Åkerblom H K., Viikari J, Uhari M, et al. Atherosclerosis precursors in Finnish children and adolescents. I. General description of the corss-sectional study of 1980 and an account of the children's and families' state of health. Acta Paediatr Scand 1985; 49–63, Suppl 318
   Google Scholar
• Solakivi-Jaakkola T, Nikkari T, Viikari J, et al. Atherosclerosis precursors in Finnish children and adolescents. VI. Serum apolipoproteins A-l and B. Acta Paediatr Scand 1985; 119–25, Suppl 318
   Google Scholar
• Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest 1987; 47: 739–44
   PubMed Web of Science ®Google Scholar
• Siedel J, Hägele E O., Ziegenhorn J, Wahlefeld A W. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983; 29: 1075–80
   PubMed Web of Science ®Google Scholar
• Wahlefeld A W. Triglycerides—determination after enzymatic hydrolysis. Methods of enzymatic analysis, H V. Bergmeyer. Academic Press, New York, London 1974; 1831
   Google Scholar
• Kostner G M. Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 1976; 22: 695
   PubMed Web of Science ®Google Scholar
• Friedewald W T., Levy R I., Fredrickson D S. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Orchard T J., Rodgers M, Hedley A J., Mitchell J RA. Changes in blood lipids and blood pressure during adolescence. Br Med J 1980; 28: 1563–7
   Web of Science ®Google Scholar
• Dacou-Voutetakis C, Trichopoulou A, Papazissis G, et al. Serum cholesterol concentration in Greek pupils aged 9–18 years. The effect of puberty. Acta Paediatr Scand 1981; 70: 257–8
   PubMedGoogle Scholar
• Viikari J, Åkerblom H K., Nikkari T, et al. Atherosclerosis precursors in Finnish children and adolescents. IV. Serum lipids in newborns, children and adolescents. Acta Paediatr Scand 1985; 103–9, Suppl 318
   Google Scholar
• Räsänen L, Ahola M, Kara R, Uhari M. Atherosclerosis precursors in Finnish children and adolescents. VIII. Food consumption and nutrient intakes. Acta Paediatr Scand 1985; 103–9, Suppl 318
   Google Scholar
• Salonen J T., Puska P, Kottke T E., Tuomilehto J. Changes in smoking, serum cholesterol, and blood pressure levels during a community-based cardiovascular disease prevention program, The North Karelia Project. Am J Epidemiol 1981; 114: 81–94
   PubMed Web of Science ®Google Scholar
• Tikkanen M J., Huttunen J K., Ehnholm C, Pietinen P. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high-fat diet. Arteriosclerosis 1990; 10: 285–8
   PubMedGoogle Scholar
• Kesäniemi Y A., Ehnholm C, Miettinen T A. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987; 80: 578–81
   PubMed Web of Science ®Google Scholar
• Miettinen T A., Gylling H, Vanhanen H. Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet 1988; ii: 1261
   Google Scholar